Soumyadeep Dey
Overview
Explore the profile of Soumyadeep Dey including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
447
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lee J, Dey S, Rajvanshi P, Merling R, Teng R, Rogers H, et al.
Front Cell Dev Biol
. 2023 Mar;
11:1144110.
PMID: 36895793
Erythropoietin (EPO), produced in the kidney in a hypoxia responsive manner, is required for red blood cell production. In non-erythroid tissue, EPO increases endothelial cell production of nitric oxide (NO)...
2.
Gumma V, Mitra B, Dey S, Patel P, Suman S, Das S, et al.
SECRYPT
. 2022 Dec;
2022:147-157.
PMID: 36561130
In recent years, Attribute-Based Access Control (ABAC) has become quite popular and effective for enforcing access control in dynamic and collaborative environments. Implementation of ABAC requires the creation of a...
3.
Dey S, Lee J, Noguchi C
Front Pharmacol
. 2021 Oct;
12:725734.
PMID: 34603036
Erythropoietin (EPO) receptor (EPOR) determines EPO response. High level EPOR on erythroid progenitor cells gives rise to EPO regulated production of red blood cells. Animal models provide evidence for EPO...
4.
Mayer B, Nemeth K, Krepuska M, Myneni V, Maric D, Tisdale J, et al.
Clin Endocrinol (Oxf)
. 2020 Dec;
94(5):888-890.
PMID: 33314284
No abstract available.
5.
Suresh S, Alvarez J, Dey S, Noguchi C
Int J Mol Sci
. 2020 Mar;
21(5).
PMID: 32121294
Obesity remodels bone and increases bone marrow adipocytes (BMAT), which negatively regulate hematopoiesis and bone. Reduced BMAT could restore altered hematopoiesis and bone features. We analyzed the potential of erythropoietin...
6.
Dey S, Cui Z, Gavrilova O, Zhang X, Gassmann M, Noguchi C
JCI Insight
. 2020 Feb;
5(5).
PMID: 32078583
The blood hormone erythropoietin (EPO), upon binding to its receptor (EpoR), modulates high-fat diet-induced (HFD-induced) obesity in mice, improves glucose tolerance, and prevents white adipose tissue inflammation. Transgenic mice with...
7.
Suresh S, de Castro L, Dey S, Robey P, Noguchi C
Bone Res
. 2019 Nov;
7:21.
PMID: 31666996
Erythropoietin is essential for bone marrow erythropoiesis and erythropoietin receptor on non-erythroid cells including bone marrow stromal cells suggests systemic effects of erythropoietin. Tg6 mice with chronic erythropoietin overexpression have...
8.
Park J, Piknova B, Dey S, Noguchi C, Schechter A
Nitric Oxide
. 2019 Jun;
90:10-14.
PMID: 31173908
The mechanism for nitric oxide (NO) generation from reduction of nitrate (NO) and nitrite (NO) has gained increasing attention due to the potential beneficial effects of NO in cardiovascular diseases...
9.
Mayer B, Nemeth K, Krepuska M, Myneni V, Maric D, Tisdale J, et al.
Sci Transl Med
. 2017 Dec;
9(418).
PMID: 29187641
Arginine vasopressin (AVP) made by hypothalamic neurons is released into the circulation to stimulate water resorption by the kidneys and restore water balance after blood loss. Patients who lack this...
10.
Dey S, Noguchi C
Vitam Horm
. 2017 Jun;
105:101-120.
PMID: 28629513
Erythropoietin (EPO), known primarily for its erythropoietic activity, is commonly used clinically to treat anemia of chronic kidney disease. However, the expression of EPO receptor (EpoR) beyond erythroid tissue provides...